Abstract
Long-term dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor (clopidogrel, prasugrel, or ticagrelor) is recommended after acute coronary syndrome (ACS) to reduce the risk of secondary ischemic events. DAPT is recommended for at least 12 months after ACS, with prolonged DAPT suggested in patients with low bleeding risk. Nurse practitioners have an important role in managing patients after ACS, acting as patient advocates and collaborating with the cardiology provider to ensure adherence to DAPT. This review describes current recommendations for DAPT in patients with ACS and the nurse practitioners role in maximizing benefits of antiplatelet therapy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
